Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
β Cell tone is defined by proglucagon peptides through cAMP signaling
Megan E. Capozzi, … , David A. D’Alessio, Jonathan E. Campbell
Megan E. Capozzi, … , David A. D’Alessio, Jonathan E. Campbell
Published February 5, 2019
Citation Information: JCI Insight. 2019;4(5):e126742. https://doi.org/10.1172/jci.insight.126742.
View: Text | PDF
Research Article Endocrinology Metabolism

β Cell tone is defined by proglucagon peptides through cAMP signaling

  • Text
  • PDF
Abstract

Paracrine interactions between pancreatic islet cells have been proposed as a mechanism to regulate hormone secretion and glucose homeostasis. Here, we demonstrate the importance of proglucagon-derived peptides (PGDPs) for α to β cell communication and control of insulin secretion. Signaling through this system occurs through both the glucagon-like peptide receptor (Glp1r) and glucagon receptor (Gcgr). Loss of PGDPs, or blockade of their receptors, decreases insulin secretion in response to both metabolic and nonmetabolic stimulation of mouse and human islets. This effect is due to reduced β cell cAMP and affects the quantity but not dynamics of insulin release, indicating that PGDPs dictate the magnitude of insulin output in an isolated islet. In healthy mice, additional factors that stimulate cAMP can compensate for loss of PGDP signaling; however, input from α cells is essential to maintain glucose tolerance during the metabolic stress induced by high-fat feeding. These findings demonstrate an essential role for α cell regulation of β cells, raising the possibility that abnormal paracrine signaling contributes to impaired insulin secretion in diabetes. Moreover, these findings support reconsideration of the role for α cells in postprandial glucose control.

Authors

Megan E. Capozzi, Berit Svendsen, Sara E. Encisco, Sophie L. Lewandowski, Mackenzie D. Martin, Haopeng Lin, Justin L. Jaffe, Reilly W. Coch, Jonathan M. Haldeman, Patrick E. MacDonald, Matthew J. Merrins, David A. D’Alessio, Jonathan E. Campbell

×

Figure 5

Proglucagon products set the tone for insulin secretion in human islets.

Options: View larger image (or click on image) Download as PowerPoint
Proglucagon products set the tone for insulin secretion in human islets....
(A) Insulin secretion from human islets with or without 1 μM Ex9 and 10 μg/ml GRA stimulated with 10 mM glutamine or 1 mM arginine (n = 3). (B) Insulin secretion in response to different combinations of 2.7 mM glucose, 10 mM glucose, 1 μM diazoxide (Dz), or Dz with 30 mM KCl, as indicated, from human islets with or without 1 μM Ex9 and 10 μg/ml GRA (n = 3). (C) Insulin secretion in response to increasing doses of IBMX in human islets with or without 1 μM Ex9 and 10 μg/ml GRA (n = 3). (D) Insulin secretion from human islets with or without 1 μM Ex9 and 10 μg/ml GRA (n = 3) stimulated with 10 nM glucagon or 50 nM GIP. (E) Insulin secretion from human islets with or without 1 μM Ex9 and 10 μg/ml GRA (n = 3) in response to low-glucose conditions. (F) Insulin secretion from human islets in response to increasing glucose concentrations with or without 1 μM Ex9 and 10 μg/ml GRA (n = 3). *P < 0.05. Data are shown as mean ± SEM. Data were analyzed by a 2-way ANOVA of the iAUCs (A, B, D, and F) or a 2-tailed Student’s t test (C).

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts